ArticlesPaediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT
Santos RD, Ruzza A, Hovingh GK, et al.
Journal: Lancet Diabetes Endocrinol
First published: October 1, 2022 DOI: 10.1016/S2213-8587(22)00221-2
Santos RD, Ruzza A, Hovingh GK, et al.
Journal:Lancet Diabetes Endocrinol
First published: October 1, 2022 DOI: 10.1016/S2213-8587(22)00221-2